Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.04/Share

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.04), versus ($0.21) reported last year.

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery